Abstract | BACKGROUND: METHODS: RESULTS:
Anastomotic leaks occurred in 13 of 53 patients (25.5%) and anastomotic stenosis occurred in 24 of 53 patients (45.3%). Median follow-up was 20 months. Logistic regression analysis showed that mean dose, V20-V40, age, co-morbidity, method of anastomosis, operating time and interval between last radiotherapy treatment and surgery were not predictors of anastomotic leakage and stenosis. CONCLUSIONS:
|
Authors | Marijn Koëter, Maurice J C van der Sangen, Coen W Hurkmans, Misha D P Luyer, Harm J T Rutten, Grard A P Nieuwenhuijzen |
Journal | Radiation oncology (London, England)
(Radiat Oncol)
Vol. 10
Pg. 59
(Mar 06 2015)
ISSN: 1748-717X [Electronic] England |
PMID | 25884226
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adenocarcinoma
(mortality, pathology, therapy)
- Adult
- Aged
- Aged, 80 and over
- Anastomosis, Surgical
- Anastomotic Leak
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Carboplatin
(administration & dosage)
- Carcinoma, Squamous Cell
(mortality, pathology, therapy)
- Chemoradiotherapy
- Combined Modality Therapy
- Esophageal Neoplasms
(mortality, pathology, therapy)
- Esophagectomy
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Paclitaxel
(administration & dosage)
- Postoperative Complications
- Prognosis
- Radiotherapy Dosage
(standards)
- Survival Rate
|